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ABSTRACT

AN INFECTION MODEL FOR EXAMINING THE EFFECTS OF GENDER AND
DIABETIC STATE ON PROINFLAMMATORY CYTOKINE SECRETION
BY PHAGOCYTIC CELLS IN RESPONSE TO INFECTION WITH
BURKHOLDERIA PSEUDOMALLEI

Laura L. Dickey
Department of Microbiology and Molecular Biology
Master of Science

Burkholderia pseudomallei is an opportunistic soil pathogen that causes melioidosis, a
life-threatening human disease prevalent in Southeast Asia, northern Australia, the
Middle East, Africa, and South America. The organism also causes disease in plants and
animals. Persons with severe melioidosis usually die of septicemia. Relatively little is
known regarding the virulence mechanisms of B. pseudomallei; however, several putative
virulence determinants have been identified. The organism is able to invade and replicate
within phagocytic cells and is particularly pathogenic in males with diabetes mellitus. B.
thailandensis is closely related to B. pseudomallei, but is not pathogenic. This study
examined various in vitro monocyte / macrophage infection models used to study innate

immune responses to B. pseudomallei. Several monocyte and macrophage models
showed little or no significant differences between proinflammatory cytokines secreted in
response to infection with B. pseudomallei and B. thailandensis. Peripheral blood
monocytes from diabetic males produced lower normalized levels of proinflammatory
cytokines IL-1α, IL-1β, IL-6, and IL-8 than monocytes from healthy males in response to
infection with B. pseudomallei, B. thailandensis, and E. coli. Surprisingly, normalized
levels of secreted IL-1β from B. pseudomallei-infected monocytes from diabetic females
were higher than levels from healthy females. The results revealed a significant
interactive effect of gender and diabetic state on peripheral blood monocyte secretion of
IL-1β (p = 0.0370) and IL-8 (p = 0.0390), as well as a significant interactive effect of
diabetic state and type of infectious agent on peripheral blood monocyte secretion of IL1α (p=0.0210) and IL-6 (p=0.0204). These results may help explain why diabetic males
are unusually susceptible to infection with B. pseudomallei.

ACKNOWLEDGMENTS

I wholeheartedly thank my parents for praying for my project every day for the last three
years (don’t try to deny it, Mom – I know you) and for teaching me to work hard, be honest, and
cheerfully keep on keepin’ on with a good sense of humor and proper perspective.
I also sincerely thank Dr. Richard Robison for all his support, mentorship and patience
with me during my years at BYU; for creating a positive and fun learning environment in his
laboratory; for never asking me to go away when I’ve knocked on his door, often for the
twentieth that day; and for teaching me so much about microbiology and scientific method.
Thanks to Dr. Byron Murray for (ahem…) ensuring that I learn my signal transduction
pathways and molecular processes and for all the many, many hours he has devoted to the
graduate students in our program. Thanks to Dr. Bill McCleary for his friendship and
mentorship, for teaching me to ask salient questions and to examine assumptions, inferences, and
conclusions carefully and critically, and for caring so much about his students.
Thanks to Spendlove Research and Justin Hoopes for generously donating many
cytokine assays, as well as their sample-testing services; to Marissa Cohen, Spencer
Pruitt, DJ Harvey, Alvin Stuart, David Tomer and TJ Hart for their help and for making
the lab a fun place; to Jay Jevne, Julie Johnson, Owen Young, and all other donors for
their blood; to Alesia Cheatham and Erin White for their blood-drawing skills; to my
brother Michael, his wife Jill, and their children Mary Kate, Jonathan, Jeffrey for
providing a haven during my years at BYU; to Lubna Abdel-Latif for the laughter and
tears (related to aforementioned signal transduction pathways), and to Chris Dye, whose
love and support have been indispensable, and who remains my favorite distraction.

vii

Table of Contents
Table of Contents.............................................................................................................. vii
List of Tables ................................................................................................................... viii
List of Figures .................................................................................................................... ix
Introduction......................................................................................................................... 1
Characteristics of Burkholderia pseudomallei................................................................ 1
Taxonomy and phylogeny........................................................................................... 1
Clinical Manifestations. .............................................................................................. 2
Epidemiology.............................................................................................................. 3
Putative virulence factors................................................................................................ 3
Capsular polysaccharide. ............................................................................................ 4
Type-III secretion systems.......................................................................................... 4
Flagella........................................................................................................................ 5
Lipopolysaccharide. .................................................................................................... 5
Cable pili..................................................................................................................... 6
Quorum sensing. ......................................................................................................... 6
Actin-based motility.................................................................................................... 7
Morphotype switching. ............................................................................................... 7
Other putative virulence factors.................................................................................. 7
Comparisons to B. thailandensis..................................................................................... 8
Host immune responses in melioidosis........................................................................... 9
Survival and replication in phagocytic cells. ............................................................ 10
Adaptive immune responses to B. pseudomallei. ..................................................... 11
Diabetes mellitus – a risk factor for melioidosis .......................................................... 11
Predisposing risk factors. .......................................................................................... 11
Cytokine profiles in melioidosis ................................................................................... 12
Specific aims of this study ............................................................................................ 14
Aim 1: U937 infection study: ................................................................................... 15
Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study................... 15
Aim 3: IL-1β Study.................................................................................................. 15
Aim 4: Diabetes mellitus infection study................................................................. 15
Materials and Methods...................................................................................................... 17
Results............................................................................................................................... 24
Aim 1: U937 infection study ........................................................................................ 24
Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study....................... 25
Aim 3: IL-1β study ...................................................................................................... 27
Aim 4: Diabetes mellitus infection study..................................................................... 28
Discussion ......................................................................................................................... 30
Aim 1: U937 infection study ........................................................................................ 30
Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study....................... 30
Aim 3: IL-1β study ...................................................................................................... 33
Aim 4: Diabetes mellitus infection study..................................................................... 33
Reference .......................................................................................................................... 55

viii

List of Tables
Table 1 Cytokines, Producer Cells, and Known Functions. ............................................ 40

ix

List of Figures
Figure 1. B. pseudomallei demonstrates variable colony morphologies in pure culture. 41
Figure 2. Cytokine production by PMA-differentiated U937 macrophage-like cells
infected with B. pseudomallei, B. thailandensis, S. aureus, or E. coli. ...................... 42
Figure 3. Kinetics of cytokine production by undifferentiated U937 monocyte-like cells
infected with B. pseudomallei, B. thailandensis, or E. coli. ....................................... 43
Figure 4. Kinetics of cytokine production by PMA-differentiated U937 macrophage-like
cells infected with B. pseudomallei, B. thailandensis, or E. coli................................ 44
Figure 5. Kinetics of cytokine production by primary peripheral blood monocytes
infected with B. pseudomallei, B. thailandensis, or E. coli. ....................................... 45
Figure 6. Kinetics of cytokine production by primary peripheral blood monocyte-derived
macrophages infected with B. pseudomallei, B. thailandensis, or E. coli. ................. 46
Figure 7. IL-1β production by primary peripheral blood monocytes infected with B.
pseudomallei, B. thailandensis, or E. coli................................................................... 47
Figure 8. TNF-α production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli. ................ 48
Figure 9. IL-1α production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli. ................ 49
Figure 10. IL-1β production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli. ................ 50
Figure 11. IL-6 production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli. ................ 51
Figure 12. IL-8 production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli. ................ 52
Figure 13. IL-13 production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli. ................ 53
Figure 14. Production of IL-4 by primary monocytes from diabetic and control subjects
in response to infection with B. pseudomallei, B. thailandensis, and E. coli. ............ 54

1

Introduction
Burkholderia pseudomallei is an opportunistic soil pathogen that causes melioidosis, a
life-threatening, human disease prevalent in Southeast Asia, northern Australia, the
Middle East, Africa, and South America. The organism also causes disease in plants and
animals.
B. pseudomallei is resistant to many antibiotics (18) and environmental extremes;
in fact, it can survive in triple-distilled water for years (72). Melioidosis results in death
in almost 100% of non-treated patients. The Center for Disease Control (CDC) has
identified B. pseudomallei as a Category B select agent that could be used as a biological
weapon. There is currently no vaccine available for melioidosis.

Characteristics of Burkholderia pseudomallei
Taxonomy and phylogeny. Burkholderia species were previously classified in the
genus Pseudomonas; however, in 1991, Yabucci et al. proposed that seven species in the
Pseudomonas RNA homology group II be classified under a new genus, Burkholderia
(74). B. pseudomallei is a gram-negative, motile, aerobic bacillus whose genome is
composed of two chromosomes. The larger chromosome (4.07 Mb) contains so-called
housekeeping genes required for cellular growth and maintenance, while the smaller
chromosome (3.17 Mb) contains accessory genes needed for functions such as adaptation
and survival in harsh conditions (69).
The Burkholderia genus comprises over thirty species. B. mallei is primarily an
equine, zoonotic pathogen that causes either chronic infections characterized by nasal and
subcutaneous nodules, or acute infections that can result in nodular formation in the lungs,
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ulcerated mucous membranes, severe septicemia, and death. B. cepacia is a human
pathogen that often causes pneumonia in individuals with underlying lung diseases such
as cystic fibrosis.
B. thailandensis is closely related to B. pseudomallei, but exhibits 105-fold less
virulence in Syrian hamsters and mice (9). The two bacteria coexist in tropical soils, and
were originally classified as the same species. In 1998, Brett et al. proposed that the
species B. thailandensis be created because of differences in virulence (9), biochemical
profiles (73), and 16S rRNA nucleotide sequences (9). Because of its high similarity to B.
pseudomallei, B. thailandensis has been used in comparative virulence studies with B.
pseudomallei (33, 70).
Other Burkholderia species include numerous plant pathogens, as well as
nonpathogenic soil dwellers that interact with plants and whose activities include iodinin
production and nitrogen fixation (15). Recently, Mao et al. identified a novel
Burkholderia strain designated MP-1 that produces antifungal compounds active against
various filamentous plant fungi (39).
Clinical Manifestations. Melioidosis is a febrile illness that can present in many forms,
ranging from acute severe septicemia to chronic, debilitating, localized infections (13).
Most patients display purulent abscesses in one or more tissues. The lungs are the most
commonly affected organs, but the disease also frequently targets the liver, spleen,
skeletal muscle, prostate, kidneys, meninges, skin, eyes, and brain. B. pseudomallei has
been shown capable of infecting almost every organ in the human body.
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Epidemiology. Melioidosis is prevalent in tropical regions within approximately 20˚ N
and 20˚ S of the equator (13). The disease is most commonly recognized in the northeast
province Ratchathani, Thailand, where B. pseudomallei is responsible for 20% of all
community-acquired septicemias and causes death in 40% of treated patients (68). It is
also a common pathogen in northern Australia, where the overall mortality rate is about
20% (12) and where in 1998, the annual incidence of melioidosis reached 41.7 cases per
100,000 (13).
B. pseudomallei is an environmental saprophyte that occurs widely in the soil and
water in areas where the disease is endemic. The majority of melioidosis cases result
from direct contact with contaminated soil and water (19). Humans and animals are
believed to acquire the pathogen by inhaling dust, ingesting contaminated water, or
directly acquiring the organism from soil (19), presumably through skin abrasions.
In many cases, clinical manifestations do not present until many years after initial
contact with the organism. Ngauy et al. reported the case of a diabetic World War II
veteran who did manual labor as a Japanese prisoner of war for two years in Thailand and
other areas in Southeast Asia 62 years before presenting with a cutaneous, nonhealing
ulcer that was found to be infected with B. pseudomallei (44). The organism was one of
the primary etiological agents of death subsequent to contamination of battle wounds in
the Vietnam War. Its ability to remain latent in the body for years before causing disease
earned B. pseudomallei the fitting designation of the ‘Vietnam time bomb’ (65).

Putative virulence factors
Compared to other gram-negative pathogens, very little is known regarding the virulence
mechanisms of B. pseudomallei. Several putative virulence factors that have been
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identified are discussed below. Most of these are involved in evading host innate
immunity; however, extensive research in this area is needed to further elucidate the hostpathogen interactions and molecular mechanisms involved in B. pseudomallei
pathogenesis. In addition, the mechanisms involved in latency are completely unknown.
Capsular polysaccharide. Burkholderia pseudomallei produces an extracellular
polysaccharide capsule composed of (-3)-2-O-acetyl-6-deoxy-ß-D-manno-heptopyranose(1-). Reckseidler et al. showed that a B. pseudomallei strain with a loss-of-function
mutation in a gene required for capsular polysaccharide expression had an LD50 in Syrian
hamsters that was similar to the LD50 for B. thailandensis, and four orders of magnitude
higher than the LD50 for wild-type B. pseudomallei (48). They later showed that
production of the capsular polysaccharide contributed to evasion of death due to
complement activation by reducing complement factor C3b deposition and opsonization
(49).
Type-III secretion systems. Genes encoding three separate type-III secretion systems
have been identified in the B. pseudomallei genome. The first two (TTSS1 and TTSS2)
are similar to those found in Ralstonia solanacearum, a plant pathogen. The third system
(TTSS3) is homologous to the type-III secretion system found in Salmonella
typhimurium (4). Warawa et al. demonstrated that TTSS3 is necessary for full virulence
in a hamster model; however, they did not observe any attenuated virulence when they
individually mutated several TTS-related effector molecules (67). Stevens et al. showed
that B. pseudomallei strains with mutations in the bsa locus, which encodes proteins
involved in a secretion system similar to the Salmonella Inv/Spa/Prg and Shigella
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Inv/Mxi-Spa secretion systems, exhibited reduced phagocyte replication, decreased
ability to escape phagocytic vacuoles, and lack of formation of membrane protrusions
and actin tails (54).
Flagella. B. pseudomallei flagella have been proposed as both potential vaccine targets
and putative virulence factors; however, antithetical sets of evidence render the latter
clause controversial. DeShazer et al. demonstrated that there was no significant
difference in the LD50 of wild-type B. pseudomallei and aflagellate mutants when tested
in Syrian hamsters and diabetic mice models (21). Chua et al. showed that while an
aflagellate B. pseudomallei mutant was not impaired in its ability to invade and replicate
within human epithelial lung cells in vitro or kill nematodes in slow-killing assays, the
mutant was avirulent compared to wild-type strains in BALB/c mice infected intranasally
and intraperitoneally (14). This suggests that flagella may contribute to virulence in an
infection route-dependent manner. Boonbumrung et al. used swim and swarm assays to
demonstrate that 205 clinical isolates obtained from melioidosis patients at
Sappasithiprasong Hospital (in northeast Thailand) showed highly conserved flagella
expression; however, they found no correlation between motility and clinical outcomes
such as septicemia and death (7).
Lipopolysaccharide. The role of lipopolysaccharide (LPS) in the pathogenesis of
melioidosis is unclear. The LPS of gram-negative bacteria is commonly associated with
septic shock caused by cytokine overload, and this phenomenon frequently causes death
in severe cases of melioidosis; however, the LPS of B. pseudomallei is different from the
LPS of other gram-negative bacteria. Matsuura et al. speculated that the LPS fatty acid
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tails are longer in B. pseudomallei than in other gram negative bacteria. They
demonstrated that B. pseudomallei LPS was less pyrogenic in rabbits, less lethally toxic
in mice, less able to activate macrophages, and had stronger mitogenic activity in murine
splenocytes than enterobacterial LPS (41). Anuntagool et al. showed that LPS from B.
pseudomallei and the LPS from B. thailandensis are immunologically indistinguishable
(3). The LPS from several other gram-negative bacteria is recognized by Toll-like
receptor 4 (TLR4), a signaling molecule that associates with macrophage receptor CD14
and facilitates the release of inflammatory cytokines (58). An interaction between B.
pseudomallei LPS and TLR4 has not been described. C3H/HeJ mice, which are defective
in TLR4-mediated signaling and hyporesponsive to infections with most gram-negative
bacteria, are highly resistant to infection with B. pseudomallei (41).
Cable pili. Cable pili are peritrichous adherence organelles that mediate binding of
bacteria to host epithelial cells and mucin. Open reading frames in B. pseudomallei
encode seven putative type IV pili. Mutations in a gene predicted to encode a type IV A
pilus structural protein led to attenuated virulence in a hamster model and reduced
adherence to human epilthelial cells (23).
Quorum sensing. Quorum sensing enables bacteria to communicate with other bacteria
in a density-dependent manner and to coordinate behavior via signaling molecules.
Ulrich et al. demonstrated that B. pseudomallei encodes at least three luxI and five luxR
homologues involved in virulence. They used mass spectrometry analysis of culture
supernatants to reveal that the organism produced many signaling molecules, including
N-octanoyl-homoserine lactone, N-decanoyl-homoserine lactone, N-(3-hydroxyoctanoyl)-
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-homoserine lactone, N-(3-hydroxydecanoyl)-L-homoserine lactone, and N-(3-

L

oxotetradecanoyl)-L-homoserine lactone. They also demonstrated that B. pseudomallei
strains with mutations in putative quorum sensing genes had increased times to death and
reduced organ colonization in infected BALB/c mice (61).
Actin-based motility. Once B. pseudomallei has been internalized by host cells, the
organism can escape endocytic vacuoles into the cytoplasm, induce formation of
membrane protrusions, and facilitate cell-to-cell spread via actin-based motility.
Breitbach et al. demonstrated that the organisms induce actin rearrangement in animal
host cells by recruitment and incorporation of α-actinin and the Arp 2/3 complex (8).
Stevens et al. identified a previously unknown bacterial factor, BimA, and demonstrated
that it was required for B. pseudomallei actin-based intracellular motility (55).
Morphotype switching. It has long been known that pure cultures of B. pseudomallei
exhibit many different colony morphologies. Some researchers have hypothesized that
the organisms undergo a process of adaptation in which they alter their surface
determinants in various host environments. Recent studies by Peacock et al. have
classified seven different isogenic types and demonstrated the organism’s ability to
undergo morphotype switching in vivo during various growth conditions. Mixed
morphotypes were present in individual clinical specimens. In addition, some
morphotypes were associated with latent infections while others were associated with
acute infections (11).
Other putative virulence factors. In addition to the factors described above, B.
pseudomallei cells are resistant to host defenses such as defensins and dismutase, and
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secrete a variety of cell-damaging products (13). B. pseudomallei is able to invade many
types of eukaryotic cell lines, including epithelial cells, neutrophils, and macrophages.
After being engulfed by professional phagocytes, the bacteria are able to escape from the
phagosome and replicate in the cytosol (30, 54).

Comparisons to B. thailandensis
Because B. pseudomallei and B. thailandensis are closely related and differ primarily in
their ability to cause disease, many researchers have used comparative bioinformatics to
study the genomic and proteomic differences between the two species in an effort to
elucidate B. pseudomallei’s mechanisms of pathogenesis.
Interestingly, B. thailandensis contains a nine-gene, arabinose-assimilation operon
that is absent in both B. pseudomallei and B. mallei. Chromosomal studies by Moore et
al. indicate that the operon was deleted from B. pseudomallei and B. mallei genomes.
When the group cloned the operon into a laboratory strain of B. pseudomallei, the mutant
was less virulent than the parent strain in Syrian hamsters. The group also used
microarray analysis to demonstrate that in the presence of L-arabinose, several genes in
the TTS3 cluster of the mutant’s genome were down-regulated, suggesting that an Larabinose metabolite may play a role in the transcriptional regulation of one or more
virulence genes (43). In E. coli, the araC gene is adjacent to the L-arabinose operon and
is one of the primary proteins involved in repression and induction of the operon (35). In
V. cholerae, the AraC/XylS family member ToxT has been shown to activate the
expression of both cholera toxin and the toxin-coregulated pilus (16).
Reckseidler et al. used subtractive hybridization to compare the genomes of B.
pseudomallei and its avirulent relative B. thailandensis in an effort to identify virulence
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determinants of the former. They found several A-T-rich DNA sequences unique to
B. pseudomallei. One of these regions was identified as the capsular polysaccharide gene
cluster discussed previously (48).
Kespichayawattana et al. showed that B. pseudomallei was able to more
efficiently invade and adhere to epithelial cells than B. thailandensis (33). Recently
Wontrakoongate et al. used two-dimensional gel electrophoresis and mass spectrometry
to compare the proteomic profiles of the two species. They found two proteins expressed
in B. pseudomallei that are not expressed in B. thailandensis under certain growth
conditions (70). The role of these proteins in virulence will likely be the focus of future
research.

Host immune responses in melioidosis
Innate immunity in humans is mediated by mechanisms that include physical barriers
provided by epithelial cells, phagocytic clearance of foreign entities, and inflammation of
infected tissues. Many of these mechanisms have been studied with regard to B.
pseudomallei infection.
Epithelial cell invasion. Tight junctions between epithelial cells in skin and the mucosal
membranes of the respiratory, gastrointestinal, and urogenital tracts provide a protective
barrier between the body and the pathogen-ridden environment. Studies by Jones et al.
demonstrated the ability of B. pseudomallei to invade rat alveolar macrophages,
monocyte-like U937 cells, and HeLa cells (30). Utaisincharoen et al. showed that B.
pseudomallei stimulated IL-8 production at levels significantly lower than those induced
by S. typhi at the cell surface without being internalized (62). They later showed that
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invasion of epithelial cells by B. pseudomallei required p38 mitogen-activated protein
kinase phosphorylation, and confirmed that B. pseudomallei could stimulate p38
phosphorylation via surface contact without internalization-mediated interactions with
intracellular cytoplasmic components (63). Kespichayawattana et al. demonstrated that B.
psdeudomallei is more efficient than B. thailandensis in adhering to and invading
cultured epithelial cells (33), indicating that epithelial-cell manipulation may contribute
to B. pseudomallei pathogenicity.
Survival and replication in phagocytic cells. Circulating monocytes leave the
vasculature and mature into macrophages in various tissues. Neutrophils are not
abundant in normal tissues, but are recruited to sites of inflammation. When
microorganisms cross the epithelial barrier of a host, they are usually recognized by
macrophages and neutrophils bearing cell-surface receptors that can identify
microorganisms. These include mannose receptors, scavenger receptors, and CD14, a
receptor for LPS found on gram-negative bacteria. Ligation of theses receptors induces
phagocytosis of the microorganism into the macrophage or neutrophil, where it becomes
enclosed in a phagosome.
The low pH of a mature phagolysosome is lethal for most pathogens. To facilitate
pathogen killing, the phagosome fuses with one or more lysosomes containing
antimicrobial agents that are lethal to pathogens. In addition, macrophages and
neutrophils produce highly reactive nitrogen and oxygen species that can aid in pathogen
killing in a process called the respiratory burst. These compounds include nitric oxide
(NO), superoxide anion (O2-), and hydrogen peroxide (H2O2) (29).
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Jones et al. showed that B. pseudomallei can survive in U937 macrophages (30),
indicating that they are somehow able to avoid these destructive mechanisms. Studies by
Stevens et al. showed that a bsa-encoded type-III secretion system facilitates escape of B.
pseudomallei from the endosomal compartment into the cytosol and enhances cell-to-cell
spread (54). Utaisincharoen et al. demonstrated that B. pseudomallei can interfere with
inducible nitric oxide synthase (iNOS) and that macrophages infected with the organism
show decreased secretion of TNF-α (64).
Adaptive immune responses to B. pseudomallei. Kattheesan et al. stimulated
peripheral blood monocytes from patients who had recovered from melioidosis with B.
pseudomallei antigens and found that lymphocyte proliferation, INF- γ production, and
activation of CD4+ and CD8+ cells were higher than in cells from uninfected donors
treated in a similar manner. In a different study, Barnes et al. took peripheral blood
mononuclear cells from individuals in Papua New Guinea and found that in response to B.
pseudomallei stimulation, lymphocyte proliferation and IFN-γ production were much
higher in cells taken from individuals who were seropositive, but had no clinical history
of melioidosis, than in cells taken from individuals who had clinical histories of
melioidosis. This indicates that individuals with subclinical melioidosis have a stronger
cell-mediated immune response to B. pseudomallei antigens, and that such a response
might be protective against disease progression (6).

Diabetes mellitus – a risk factor for melioidosis
Predisposing risk factors. After a fourteen-year prospective study in northern Australia,
Currie et al. used a whole-population logistic regression model to estimate that the
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relative risk factors for melioidosis in males and females with diabetes mellitus were 21.2
and 13.1, respectively. The melioidosis incidence rate for this time period was estimated
at 260 cases per 100, 000 diabetics (17). In a separate study in northeast Thailand,
Supattamongkol et al. showed that diabetes mellitus was a significant factor associated
with bacteremic melioidosis (57).
Other predisposing risk factors for melioidosis include renal failure and
alcoholism. Yun-Hwen Gan suggested that that in some cases, compromised immune
function may lead to latent or chronic melioidosis, while in other cases, healthy immune
responses may lead to acute melioidosis caused by hyperinflammation; however, this
hypothesis does not explain why severe (acute) melioidosis is most often seen in type-I
diabetics or why diabetic mice are prone to acute disease caused by bacterial infection
and characterized by hyperinflammation.

Cytokine profiles in melioidosis
Humans have evolved various mechanisms for discerning foreign cells and potentially
pathogenic microbes. Toll-like receptors (TLRs) can recognize various pathogenassociated molecular patterns (PAMPs). Ligation of TLRs activates intracellular
signaling cascades that induce expression of genes involved in inflammatory and immune
responses (2).
Gram-negative bacteria are opsonized by LPS-binding protein (LBP) and the
LPS-LPB complex is recognized by CD14, a membrane-bound receptor on the surface of
phagocytic cells. CD14 and MD-2 are thought to stabilize the dimerization and
subsequent conformational change of TLR-4, a process necessary for the recruitment of
adaptor proteins containing TIR domains. TIR domains are cytoplasmic regions
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conserved among TLR and IL-1 receptors that are important in intracellular signaling.
Known adaptor proteins include MyD88, TIR-associated protein (TIRAP), TIR-domaincontaining adaptor protein-inducing IFN- β (TRIF), and TRIF-related adaptor molecule
(TRAM). In TLR-4 signaling, TIRAP recruits MyD88 to the cytoplasmic membrane,
where it associates with the receptor via homophilic interactions and recruits IL-1Rassociated kinase 4 (IRAK-4) and IRAK-1 via homophilic interactions with their death
domains. IRAK-4 phosphorylates IRAK-1, which subsequently associates with TNFRassociated factor 6 (TRAF6), a ubiquitin protein ligase. TRAF6 helps form a complex
whose activities lead to the phosphorylation of IKK-B and several MAP kinases. This
leads to the activation of the Jun/Fos and NF-κB, transcription factors that regulate the
expression of many genes involved in innate immune responses, including
proinflammatory cytokines and chemokines (1). In addition to TLR-4, monocytes
express other toll-like receptors that may recognize molecular patterns associated with B.
pseudomallei, including TLR-3, which recognizes peptidoglycan, and TLR-5, which
recognizes flagella.
Researchers have identified cytokines as critical immunoregulatory determinants
and have characterized two periods of immune response activation: the T-cellindependent pathway (early) and T-cell-dependent pathway (late). The cytokine profile
produced during the early (T-cell independent) phase activates macrophages, influences
T-lymphocyte differentiation and proliferation in the late phase, and is probably the most
salient factor in determining host innate resistance to intracellular pathogens (5).
Friedland et al. measured the plasma levels of IL-8, TNF-α, and IL-6 in
melioidosis patients throughout the disease progression until death or recovery. They
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found that concentrations of IL-6 and IL-8 were elevated throughout the infection and
that elevated plasma IL-6 correlated with 75% mortality in B. pseudomallei sepsis. IL-8
was elevated in 50% of the patients who died. TNF- α activity did not relate to disease
outcome (24); however, a study by Nuntayanuwat et al. demonstrated that polymorphism
in the TNF-α promoter region and corresponding levels of TNF-α production were
significantly higher in patients with severe melioidosis compared to control subjects (45).
Ulett et al. showed that in primary infections with B. pseudomallei, cytokine
responses involve the proinflammatory regulators TNF-α and IL-6 rather than polarized T
helper cell patterns (59). They also demonstrated that in susceptible BALB/c mice,
cytokine profiles were similar, but less pronounced in response to respective infections
with high-virulence and low-virulence strains of B. pseudomallei (59). The group then
showed that in B. pseudomallei-infected BALB/c mice, a model researchers use to study
acute melioidosis, liver levels of the proinflammatory cytokines IL-6, TNF- α, and IL-1β
mRNA were significantly elevated, while the same mRNA levels in B. pseudomalleiinfected C57BL/6 mice (used to study chronic melioidosis) were only moderately
elevated (60). Lauw et al. found that compared to healthy controls, melioidosis patients
had elevated plasma concentrations of IFN-γ, IL-18, IL-12, and IL-15 (36).

Specific aims of this study
The purpose of this study was to examine in vitro innate immune responses to B.
pseudomallei infection with regard to cytokine expression profiles produced by
phagocytic cells. There were four specific aims for this study:
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Aim 1: U937 infection study: The first aim was to determine whether there are
differences in the proinflammatory cytokine expression profiles produced by PMAdifferentiated U937 macrophage-like cells in response to infection with B. pseudomallei
and B. thailandensis.

Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study. The second
aim was to compare various monoctye / macrophage infection models to determine a)
whether there are differences between B. pseudomallei- and B. thailandensis-induced
cytokine profiles in the respective models, and b) at what point post infection maximum
activity of proinflammatory cytokines was observed in the various models. Four models
were used for this study: 1) Undifferentiated U937 monocyte-like cells (no PMA used), 2)
PMA-differentiated U937 macrophage-like cells, 3) Primary peripheral blood monocytes,
and 4) Primary peripheral blood monocyte-derived macrophages.

Aim 3: IL-1β Study. The third aim was to characterize IL-1β secretion in primary
human peripheral blood monocytes infected with B. pseudomallei, B. thailandensis, and
E. coli.

Aim 4: Diabetes mellitus infection study. The fourth aim was to examine the
differences between cytokine profiles in B. pseudomallei-infected peripheral blood
monocytes from healthy subjects and diabetic subjects.
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Proinflammatory cytokine secretion was studied by infecting U937 monocyte-like or
macrophage-like cells and primary human peripheral blood monocytes or monocytederived macrophages from healthy and diabetic donors with B. pseudomallei, B.
thailandensis, S. aureus, and E. coli. Cytokine production by phagocytic cells from
diabetic patients in response to B. pseudomallei infection has not been previously
described.
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Materials and Methods
Blood donors: Persons with type-I diabetes mellitus and healthy age-gender matched
controls were recruited via flyers and personal communication. Protocols involving
human blood donors followed federal regulations and were approved by the Brigham
Young University Institutional Review Board (IRB).
Growth calibration curves. Bacterial cultures were grown overnight in 10 ml of brain
heart infusion (BHI) broth in 50-ml conical tubes with loose caps at 37°C without
shaking. Five ml of each species were collected (below the pellicle, when applicable),
centrifuged at 3645 X g, washed, and suspended in supplemented RPMI media. Serial
dilutions were made for each species (1:2, 1:4, 1:8, 1:16, 1:160, 1:1600, 1:16,000, 1:1.16
x 105, 1:1.16 x 106, 1:1.16 x 107 1:1.16 x 108 1:1.16 x 109, and 1:1.16 x 1010). OD
readings were recorded for the 1:1, 1:2, 1:4, 1:8, and 1:16 suspensions, and 1-ml samples
of the 1:1.16 x 107 1:1.16 x 108 1:1.16 x 109, and 1:1.16 x 1010 dilutions were plated in
duplicate by membrane filtration on Columbia agar plates and incubated at 37°C.
Colony-forming unites (CFU) were counted after 48 hours. Second-order polynomial
regression curves were generated using Microsoft Excel® and used to interpolate
concentrations of bacteria for all experiments.
PMA preparation. One mg PMA (Sigma) was dissolved in 1 ml DMSO. A 2.5 μl
aliquot of this solution was added to 5 ml Hanks Balanced Salt Solution (HBSS)
(Hyclone) to produce a 0.5 μg/ml PMA solution. DMSO and HBSS PMA solutions were
stored at -20 °C until used.

18

Aim 1: U937 infection study
Tissue culture. U937 cells were cultured in RPMI media (Hyclone) supplemented with
1% HEPES (Cellgro), 1% sodium pyruvate (ICN Biomedicals), 0.5 g/L glucose, 1.5 g/L
sodium bicarbonate (Cellgro), and 10% bovine growth serum (BGS) (Hyclone) in a 37°C
incubator with 5% CO2. Each well in a six-well plate was seeded with 1 x 106 cells in 1
ml media and incubated overnight with 0.05 μg/ml PMA (100 μl of 0.5 μg/ml PMAHBSS solution per well). Media (without PMA) was replaced before cells were infected.
Bacteria. Bacterial strains used were Burkholderia pseudomallei ATCC 23343,
Burkholderia thailandensis ATCC 700388, Staphylococcus aureus (lab strain identified
using cellular fatty acid profiles, MIDI, Inc.), and Escherichia coli 11229. All bacterial
cultures were grown overnight in 10 ml of BHI broth at 37°C without shaking. Five ml
of culture from each strain were collected (below the pellicle, when applicable),
centrifuged at 3645 X g, washed, and resuspended in 5 ml of supplemented RPMI media
prior to use in infections. Three optical density (OD) measurements were averaged (at
580 nm for B. pseudomallei and B. thailandensis, and 600 nm for S. aureus and E. coli),
and bacteria were diluted with supplemented media as appropriate to achieve the desired
concentration of 6 x 106 cfu/ml.
Infection. One ml of the appropriate bacterial suspension was added to U937
macrophage-like cells to achieve a multiplicity of infection (MOI) of 6. After 120
minutes, one ml of media containing 750 μg/ml kanamycin was added to wells (final
kanamycin concentration was 250 μg/ml) in order to inhibit extracellular bacterial growth.
Supernatants were collected 8 hours post infection. Samples were passed through a 0.2
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μm, low-protein-binding, Durapore PVDF filters (Millipore) to remove cells, and tested
immediately for levels of TNF-α, IL-1β, and IL-6.
Cytokine assays. Levels of TNF-α, IL-1β, and IL-6 were determined using Quantikine
ELISA assays (R&D Systems). Manufacturer instructions were followed.

Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study
Tissue culture. Cell line: U937 cells were cultured as described above. Primary human
peripheral monocytes: 50 ml whole blood was collected from two healthy donors in
K3EDTA vacutainers (Becton Dickinson) and diluted 1:1 with Hanks Balanced Salt
Solution (HBSS) (Hyclone). Approximately 25 ml blood-HBSS solution was carefully
layered over 10 ml Lymphocyte Separation Medium (LSM) (Mediatech) and centrifuged
at 600xg for 25 minutes. The mononuclear cells were collected between the LSM and
plasma layer and resuspended in 13 ml RPMI media supplemented with 1% HEPES, 1%
sodium pyruvate, 0.5 g/L glucose, 1.5 g/L sodium bicarbonate, and 10% BGS. Cells
were seeded in 6-well plates with 2 ml media, and incubated at 37°C with 5% CO2. Cells
from one donor were incubated for five days with media changes every other day to
allow them to differentiate into macrophages. Cells from the other donor were incubated
for one day and washed twice before use to remove nonadherent cells. Immediately prior
to the infection assays, one well of each plate was treated with 0.5 ml Trypsin (Invitrogen)
and the cells were gently detached from the well bottom with a cell scraper (Corning).
Monocyte concentrations from trypsin-treated wells were determined with a
hemacytometer.
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Bacteria. Bacterial strains used were Burkholderia pseudomallei ATCC 23343,
Burkholderia thailandensis ATCC 700388, and Escherichia coli 11229. All bacterial
cultures were grown as described above. The concentrations of bacteria used to infect
peripheral blood monocytes were determined by multiplying the monocyte counts
obtained using the hemacytometer by six. Suspension concentrations of 6 x 106 cfu/ml
were used for the U937 monocytes and macrophages.
Infection. Monocytes were infected (MOI = 6) with 1 ml of appropriate B. pseudomallei,
B. thailandensis, and E. coli suspensions. After 90 minutes 200 μg/ml kanamycin was
added to wells to inhibit extracellular bacterial growth. Supernatant samples from B.
pseudomallei, B. thailandensis, and mock infections were collected 2, 4, 6, 10, 12, 16, 20,
and 24 hours post infection. Supernatant samples from E. coli infections were collected 2,
6, 10, 16, 20, and 24 hours post infection. Samples were passed through 0.2 μm, lowprotein-binding, Durapore PVDF filters (Millipore) to remove cells, and stored at –80°C
until they were tested.
Cytokine assays. Samples were tested for levels of IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8,
IL-10, IFN-γ, and TNF-α using multiplex cytokine ELISA assays (Q-Plex Human
Cytokine Array – Inflammation (Biolegend)). Some data points were excluded from
post-assay analysis because their corresponding ELISA CCD detection images displayed
excessively bright spots that extended well beyond capture antibody area assignment,
indicative of improperly seeded capture antibody, nonspecific detection antibody binding,
or some other malfunction.
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Aim 3: IL-1β study
Tissue culture. Fifty ml whole blood was collected from five healthy donors and
cultured as described above. Cells were incubated for 24 hours and washed twice before
infection.
Bacteria. Bacterial strains used were Burkholderia pseudomallei ATCC 23343,
Burkholderia thailandensis ATCC 700388, and Escherichia coli 11229. Bacterial
cultures were grown (and infection concentrations were determined) as described above
Infection. Monocytes were infected (MOI = 6) with B. pseudomallei, B. thailandensis,
and E. coli. After 90 minutes, 200 μg/ml kanamycin was added to wells to inhibit
extracellular growth. Supernatants were collected at 10 (n=3) and 11 (n=2) hours post
infection. Samples were passed through 0.2 μm, low-protein-binding, Durapore PVDF
filters (Millipore) to remove cells and stored at –80°C until tested.
Cytokine assays. Levels of IL-1β were determined with Quantiglo ELISA assays (R&D
systems). Manufacturer instructions were followed.

Aim 4: Diabetes mellitus infection study
Tissue culture – diabetes mellitus study. Forty-two ml of whole blood from diabetic
males (n=5), healthy males (n=6), diabetic females (n=5), and healthy females (n=6) were
collected in EDTA vacutainers (BD). In each of two 50-ml conical tubes, approximately
20 ml of whole blood was diluted with 15 ml of HBSS (Hyclone), layered over 15 ml of
LSM (Cellgro), and centrifuged at 600 X g for 25 minutes. Approximately 15 ml of
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peripheral blood mononuclear cells (PBMCs) were removed, mixed with 6 ml OptiPrep
(Accurate Chemical) and overlaid with 7.5 ml and 20 ml of OptiPrep solutions with
densities of 1.070 g/ml and 1.086 g/ml, respectively. Cells were centrifuged at 600 X g
for 25 minutes, after which the top 20 ml (faction including monocytes) were removed
and washed three times. Cells were counted and 1 x 105 cells were seeded into each well
of 12-well plates with one ml RPMI media supplemented with 1% HEPES (Cellgro), 1%
NEAA (Hyclone), 1% sodium pyruvate (ICN Biomedicals), 0.5 g/L glucose, 1.5 g/L
sodium bicarbonate (Cellgro), and 10% heat-inactivated BGS (Hyclone). Cells were
placed in a 37 °C incubator with 5% CO2 for 2 – 3 hours before infection.
Bacteria. Bacterial strains used were Burkholderia pseudomallei NCTC 13178,
Burkholderia thailandensis ATCC 700388, and Escherichia coli 11229. Bacterial
cultures were grown (and infection concentrations were determined) as described above.
Infection. Monocytes were infected (MOI = 6) with B. pseudomallei, B. thailandensis,
and E. coli. After 90 minutes 150 μg/ml kanamycin was added to wells to inhibit
extracellular bacterial growth. Supernatants were collected 10 hours post infection.
Samples were passed through 0.2 μm, low-protein-binding, Durapore PVDF filters
(Millipore) to remove cells. Samples were stored at –80°C until tested.
Cytokine assays. Samples were tested for levels of IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8,
IL-10, IFN-γ, and TNF-α using multiplex cytokine ELISA assays (Q-Plex Human
Cytokine Array – Inflammation (Biolegend)).
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Statistical analysis. Cytokine concentration data were transformed to the natural
logarithmic scale and analyzed using a linear mixed model with gender, diabetic state,
infectious agent and all possible interactions of these factors as fixed effects. Subject was
included as a random effect in the model. The model was fitted using residual maximum
likelihood for the variance components and estimated generalized least squares for the
fixed effects. Residuals were computed and plotted versus predicted values to assess
goodness-of-fit of the model. Main effects and interactions of the fixed effects were
tested using approximate F-tests based on the Kenward-Roger adjustment for smallsample inferences. Specific comparisons of means were carried out using linear contrasts.
Least squares means were computed for all combinations of the factor levels.

24

Results
Aim 1: U937 infection study
The first aim was to determine whether there were differences in the proinflammatory
cytokine expression profiles produced by PMA-differentiated U937 macrophages in
response to infection with B. pseudomallei and B. thailandensis. As mentioned
previously, the lipopolysaccharide (LPS) of B. pseudomallei is immunologically
indistinguishable from that of B. thailandensis; however, it is possible that the surface
determinants that govern host innate immune responses are different for the two species,
especially given the fact that B. pseudomallei is able to undergo morphotype switching
during various growth conditions. To test the hypothesis that proinflammatory cytokine
expression profiles produced by PMA-differentiated U937 macrophages differed in
response to infection with B. pseudomallei and B. thailandensis, U937 cells were infected
with both species in addition to E. coli (gram negative, positive control) and S. aureus
(gram-positive, negative control). Concentrations of TNF-α, IL-1β, and IL-6 were
determined using ELISA analysis.
The concentration of TNF-α was significantly higher (t-test assuming unequal
variances, p = 0.0135) in cultures infected with B. pseudomallei than in those infected
with B. thailandensis (Figure 2A); however, the results of this study do not support the
hypothesis that there are differences in secretion levels of either IL-1β (Figure 2B) or IL6 (Figure 2C) between cells infected with B. pseudomallei and cells infected with B.
thailandensis. Levels of all cytokines were negligible in response to infection with S.
aureus. In addition, cells infected with E. coli produced significantly higher levels of IL6 than any other bacterium tested (p<0.05).
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Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study
The second aim was to compare various monoctye / macrophage infection models to
determine a) whether there are differences between B. pseudomallei- and B.
thailandensis-induced cytokine profiles in the respective models, and b) at what point
post infection maximum activity of proinflammatory cytokines was observed in the
various models. Four models were used for this study: 1) Undifferentiated U937
monocyte-like cells (no PMA used), 2) PMA-differentiated U937 macrophage-like cells,
3) Primary peripheral blood monocytes, and 4) Primary peripheral blood monocytederived macrophages (peripheral blood monocytes that had been allowed to differentiate
into macrophages for 5 days).
Because U937 cells are a leukemia cell line, they may have different genotypic
and phenotypic characteristics from peripheral blood monocytes and macrophages.
Peripheral blood monocytes from healthy donors were cultured for various periods, and
their cytokine responses to B. pseudomallei, B. thailandensis, and E. coli were compared
to those of the U937 cell line.
The cytokine profiles differed for each model used. Undifferentiated U937 cells:
The levels of all assayed cytokines produced by undifferentiated U937 cells in response
to infection with Burkholderia species were negligible (Figure 3). Levels of most
cytokines were negligible in response to infection with E. coli with the exception of IL-8,
which was slightly elevated (compared to uninfected cells) throughout the infection and
was significantly elevated at 24 hours (Figure 3 and data not shown).
PMA-differentiated U937 cells: PMA-differentiated U937 cells produced
elevated levels (compared to uninfected cells) of TNF-α and IL-10 in response to
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infection with Burkholderia species (Figure 4). Cells infected with B. pseudomallei
produced similar levels of TNF-α compared to cells infected with B. thailandensis
(Figure 4a) early in the infection (2-6 hours); however, cells infected with B.
pseudomallei produced more TNF-α than cells infected with B. thailandensis (Figure 4a)
late in the infection (8 - 24 hours). Cells infected with B. pseudomallei produced more
IL-10 than cells infected with B. thailandensis later in the infection (10 – 24 hours)
(Figure 4D). PMA-differentiated U937 cells infected by various agents did not produce
significantly elevated levels of TNF-β, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-13,
and IFN-γ, with the exception of cells infected with E. coli, which produced elevated
significant levels of IL-8. (Figure 4 and data not shown).
Primary human peripheral blood monocytes: Primary human peripheral blood
monocytes produced elevated levels of TNF-α and TNF-β (Figures 4A and 4F,
respectively) and decreased levels of IL-1α, IL-6, and IL-10 (Figures 4B, 4D, and 4E,
respectively) in response to B. pseudomallei and B. thailandensis infections. These
differences occurred late in infection (16-24 hours). The cells produced substantially
lower levels of TNF-α than the peripheral blood monocyte-derived macrophages (Figures
4A and 5A, respectively). Cells infected with B. thailandensis produced significantly
elevated levels of IL-1β throughout the infection, while cells infected with B.
pseudomallei produced baseline levels of IL-1β throughout the infection. Levels of most
cytokines of interest peaked at about 10 hours post infection. Levels of IL-8 were above
detection limits in all infections (data not shown). Production of IL-2, IL-4, IL-5, IL-13,
and IFN-γ was negligible for all infections (data not shown).
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Primary human peripheral blood monocyte-derived macrophages: Primary
monocyte-derived macrophages produced elevated levels of TNF-α, IL-1α, and IL-1β
(Figures 5A, 5B, and 5C, respectively) throughout the infections with B. pseudomallei
and B. thailandensis. The cells produced decreased levels of IL-6 and increased levels of
TNF-β late in the infections with B. pseudomallei and B. thailandensis. (16-24 hours post
infection). There were no significant differences between the levels of cytokines
produced by cells infected with B. pseudomallei and B. thailandensis. Cells infected with
E. coli produced slightly elevated levels of TNF-α and significantly elevated levels of IL6 throughout infection. Levels of IL-8 were above detection limits in all infections (data
not shown). The cells did not produce significantly elevated levels of IL-2, IL-4, IL-5,
IL-10, IL-13, and IFN-γ (Figure 5 and data not shown).

Aim 3: IL-1β study
The third aim was to characterize IL-1β secretion in peripheral blood monocytes infected
with B. pseudomallei. The results from the 24-hour inflammation study indicated that
peripheral blood monocytes might respond differently to infections with B. pseudomallei
and B. thailandensis with regard to IL-1β production; however, when the experiment was
repeated with peripheral monocytes from several subjects, the differences between IL-1β
production in response to B. pseudomallei and B. thailandensis were not significantly
different for either 10-hour (Figure 7) or 11-hour (data not shown) infection periods. In
addition, there were no significant differences between B. pseudomallei- and E. coliinduced IL-1β profiles, or between B. thailandensis- and E. coli-induced IL-1β profiles
for either infection period (Figure 7 and data not shown).
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Aim 4: Diabetes mellitus infection study
The fourth aim was to examine the differences between cytokine profiles in B.
pseudomallei-infected peripheral blood monocytes from healthy subjects and diabetic
subjects. As discussed above, persons with diabetes mellitus, particularly men older than
40 years, are especially susceptible to infection with B. pseudomallei. The results from
previous studies indicate that diabetic susceptibility to bacterial infections is due to
defects in innate, rather than adaptive immunity. In this study, the ability of primary
peripheral monocytes from diabetic and nondiabetic controls to secrete various
proinflammatory cytokines and chemokines upon infection was evaluated. Fresh
peripheral blood monocytes were used in order to minimize the effects that artificial cell
culture would have on the intracellular milieu. Peripheral monocytes were infected with
B. pseudomallei, B. thailandensis, E. coli (positive control) and sterile media (negative
control). Sample supernatants were tested for levels of cytokines. Statistical analyses
were performed to examine the effects of 1) infecting agent, 2) diabetic state, and 3)
gender, on cytokine secretion by peripheral monocytes. Many of the cytokines examined
(IL-2, IL-4, IL-5, IL-13, TNF-β, and IFN-γ) have not been shown to be secreted by
monocytes, and therefore serve as negative controls. All cytokine concentrations were
normalized against corresponding concentrations in uninfected cultures.
There was no significant difference between normalized levels of TNF-α secreted
by monocytes with regard to agent, gender, or diabetic state (Figure 8A). Normalized
levels of secreted IL-1α, IL-1β, IL-6, and IL-8 were significantly higher for monocytes
from healthy males than they were for monocytes from diabetic males (Figures 9, 10, 11,
and 12, respectively) for all three infectious agents. Normalized levels of secreted IL-1β
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were significantly higher for monocytes from diabetic females than they were in
monocytes from healthy females (Figure 10) in response to infection with B.
pseudomallei. Normalized levels of IL-13 were significantly higher in samples from
diabetic females than healthy controls (Figure 13); however, IL-13 has not conclusively
been shown to be produced by macrophages and the levels produced were very low
compared to other cytokines, so it is likely that the statistical difference observed isn't
biologically meaningful. Interestingly, there was no significant difference between
normalized levels of TNF-α secreted by monocytes with regard to agent, gender, or
diabetic state (Figure 8A). Statistical analysis of this data revealed a significant
interactive effect of gender and diabetic state on peripheral blood monocyte secretion of
IL-1 β (p = 0.0370) and IL-8 (p = 0.0390). In addition, the analysis revealed a significant
interactive effect of diabetic state and infectious agent for IL-1α (p=0.0210) and IL-6
(p=0.0204).
The concentrations of TNF-β, IL-2, IL-4, IL-5, and IFN-γ were not significantly
elevated in response to infection with any agent in this study (Figure 14 and data not
shown). In addition, the concentrations of IL-10 and IL-13 (Figures 12 and 13,
respectively) were not significantly elevated in any of the experiments.
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Discussion
Aim 1: U937 infection study
Although the production of TNF-α by U937 macrophage-like cells infected with B.
pseudomallei was significantly higher (t-test assuming unequal variances, p = 0.0135)
than by those infected with B. thailandensis (Figure 2A), the cells showed no difference
in IL-1β (Figure 2B) or IL-6 (Figure 2C) production in response to the two species.
These results indicate a possible difference in the ability of B. pseudomallei and B.
thailandensis to induce TNF-α production in vitro; however it is important to keep in
mind that U937 cells are from a leukemia cell line that likely has different genotypic and
phenotypic characteristics from human cells in vivo, so caution should be used in the
extrapolation of these results to an in vivo situation. The infection of cells with S. aureus
served as a negative control since gram-positive bacteria haven’t been shown to induce
significant levels of these inflammatory cytokines.

Aim 2: Twenty-four hour, multi-model, inflammatory cytokine study
The second aim examined the kinetics and profiles of cytokine production by various cell
types. The cytokine profiles differed for each model used. The fact that undifferentiated
U937 monocyte-like cells produced insignificant cytokine levels indicate that they are a
poor model for studying innate immune responses to Burkholderia species.
Consistent with the Aim 1 study, PMA-differentiated U937 cells infected with B.
pseudomallei produced elevated levels of TNF-α compared to cells infected with B.
thailandensis late in the infection; however, these results should be interpreted cautiously
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since cells infected with B. pseudomallei also produced more IL-10 (which has been
shown to inhibit production of proinflammatory cytokines, including TNF- α) than those
infected with B. thailandensis. In addition, the same phenomenon was not observed when
primary human cells were infected. The results could be due to a unique phenotype of
the U937 cell line.
The observation that IL-6 was not significantly elevated in response to infections
is consistent with the results of the Aim 1 study, in which secreted levels of IL-6 were
negligible (Figure 2C). The fact that PMA-stimulated U937 cells produced cytokine
profiles that were significantly different from primary human monocytes and monocytederived macrophages in response to infection indicates that these cells are probably not a
good model for studying cytokine responses to Burkholderia infection.
Peripheral blood monocytes produced substantially lower levels of TNF-α than
the peripheral blood monocyte-derived macrophages (Figures 4A and 5A, respectively).
It is not clear why IL-1β production by monocytes in response to infection with B.
pseudomallei was near baseline levels, while that of cells infected with B. thailandensis
was significantly elevated throughout the infection. While it is interesting that the levels
of TNF-α produced by monocytes infected with B. pseudomallei and B. thailandensis
increased and corresponding levels of IL-1α, IL-6, and IL-10 decreased 16 hours post
infection, it should be noted that these changes were accompanied by mildly elevated
levels of TNF-β, which has not been shown to be produced by monocytes or
macrophages. This indicates that there may have been low levels of contaminating
lymphocytes in these cell preparations, and it is impossible to determine the full extent of
their effects. It is interesting, however, that the cells infected with E. coli didn’t follow
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the same trend as cells infected with Burkhoderia species, suggesting that B.
pseudomallei and B. thailandensis elicit different immune responses than other common
gram-negative bacteria. Levels of most cytokines of interest peaked at about 10 hours
post infection.
Primary monocyte-derived macrophages produced elevated levels of TNF-α, IL-1
α, and IL-1β (Figures 5A, 5B, and 5C, respectively) throughout the infection with B.
pseudomallei and B. thailandensis; however there were no significant difference between
profiles produced in response to the two infectious agents. As with the monocyte
infections, the cytokine profile patterns produced by monocyte-derived macrophages
infected with Burkholderia species were markedly different than the profiles produced by
cells infected with E. coli. Interestingly, monocyte-derived macrophages produced
decreased levels of IL-6 and increased levels of TNF-β late in the infections with B.
pseudomallei and B. thailandensis. Increased levels of TNF-β late in infection again
suggest that there were low levels of contaminating lymphocytes in these cell
preparations.
Results from these studies indicated that infection of peripheral monocytes
elucidated the most pronounced differences between infections with B. pseudomallei and
B. thailandensis. Peripheral monocytes were used for the remaining studies since they
are likely to undergo fewer modifications as a result of artificial culturing than monocytederived macrophages. In addition, the optimal time post-infection for cytokine assays
was about 10 hrs; therefore, this infection period was used in subsequent experiments.
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Aim 3: IL-1β study
The results from the 24-hour inflammation study indicated that peripheral blood
monocytes might respond differently to infections with B. pseudomallei and B.
thailandensis with regard to IL-1β production; however, when the experiment was
repeated with peripheral monocytes from several subjects, the differences between IL-1β
production in response to B. pseudomallei and B. thailandensis were not significantly
different for either 10-hour (Figure 7) or 11-hour (data not shown) infection periods.
The results from the 24-hour time course study indicating different responses to the two
species could possibly be explained by morphotype switching in response to cells from
various donors.

Aim 4: Diabetes mellitus infection study
The interactive effect of gender and diabetic state on peripheral monocyte
cytokine production in response to infection with B. pseudomallei has not been
previously reported. The current study indicates that IL-1β and IL-8 production by
infected monocytes can be influenced by a combination of gender and diabetic state. This
is particularly interesting with regard to B. pseudomallei infection, since melioidosis
occurs more often and is more severe in diabetic males.
Type I diabetes mellitus may be due to an autoimmune disorder in which the beta
cells in the Islets of Langerhans of the pancreas are attacked and killed. Beta cells
normally produce insulin, which is critical in regulating blood glucose levels.
Researchers have endeavored to determine why patients with diabetes mellitus are
more susceptible to bacterial infections than healthy persons. There is increasing
evidence that patients with diabetes mellitus have defects in their innate immunity.
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Marhoffer et al. demonstrated that neutrophils from patients with diabetes have decreased
phagocytic function (40) and Kjersem et al. showed that neutrophils from patients with
type I diabetes have impaired particle uptake after short-term hyperglycemica where
glucose concentrations reflected normal physiological concentrations (34).
Studies using peripheral blood mononuclear cells from diabetic patients indicate
that these cells have decreased chemotactic and phagocytic activity in response to gramnegative bacterial stimulation (27); however, other studies demonstrated higher baseline
levels of proinflammatory cytokines, particularly IL-1β in macrophages from diabetic
mice stimulated with lipopolysaccharide (46). In addition, Salvi et al. demonstrated that
fresh monocytes from patients with diabetes mellitus produced higher levels of secreted
IL-1β and PGE2 after overnight stimulation with Porphyromonas gingivalis and E. coli
(50). The clinical relevance of these findings is unclear. Interestingly, no in vivo defects
in adaptive immunity have been described for diabetes mellitus patients (26).
The results of the current study indicate that B. pseudomallei-infected monocytes
from diabetic males have decreased ability to secrete IL-1α, IL-1β, IL-6, and IL-8 in
comparison to monocytes from healthy, nondiabetic males. While these results may
appear to be contradictory to other studies reporting increased cytokine secretion in
response to LPS stimulation (particularly those by Salvi et al.), there are key differences
in the experiments that may account for these disparities. This study used live bacteria to
infect monocytes rather than isolated LPS to stimulate monocytes. Burkholderia
pseudomallei is an intracellular pathogen whose effects on host cell signaling are just
beginning to be elucidated, and whose associations with toll-like receptors are almost
completely uncharacterized. The differences in conclusions drawn from this study and
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those of Salvi et al. can possibly be explained by the differences in cytokine signaling
pathways induced by live, intracellular, abnormal-LPS-bearing bacteria versus isolated
LPS from common gram-negative species.
Lipid A is generally considered to be the pharmacologically active component of
LPS. While lipid A is highly conserved among gram-negative bacteria, its structure is
not invariant. Researchers have demonstrated that variations in lipid A structure can have
significant pathogenic implications. For example, Yersinia pestis produces two different
lipid A variants depending on the temperature at which the organism is grown: the
molecule is hexa-acylated in Y. pestis grown at 21 - 27 °C (flea temperatures), and tetraacylated in organisms grown at 37 °C (mammalian temperature) (32). Tetra-acylated
lipid A has been shown to have poor TLR-4-stimulating activity (37). In an elegant
experiment, Montminy et al. modified Y. pestis to produce a potent TLR-4-simulating
LPS with a lipid A structure similar to lipid A from Y. pestis grown at 21 °C.
Remarkably, the mutant was completely avirulent in mice, depite the presence of all other
known virulence determinants associated with Y. pestis pathogensis (42). Other
researchers have shown that mutations in TLR4 signaling are associated with increased
susceptibility to infection in humans (66). In addition, Lien et al demonstrated that fatty
acid composition of LPS can affect receptor binding affinity (37). It is plausible that B.
pseudomallei LPS induces poor TLR4 signaling and that this property contributes to its
ability to evade host immune responses, particularly in those individuals with underlying
modulated immune responses such as diabetics.
Some researchers have speculated that persons with type-I diabetes are more
susceptible to melioidosis because of the effects of insulin. Woods et al. hypothesized
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that insulin deficiencies directly affected the growth rate of B. pseudomallei and
demonstrated that the organism grew significantly more slowly in minimal media
containing recombinant human insulin than in control cultures containing no insulin (71).
In addition, the group showed an increase in the organism's growth rate in serum from
diabetic rats over serum from control rats and that B. pseudomallei possesses a highaffinity binding site for insulin (71). These results suggest a role for insulin in
susceptibility to B. pseudomallei infection; however, another research group has
contested such a role. Simpson et al. did a retrospective study in which they determined
that fewer than 10% of 382 patients in Thailand with diabetes mellitus who had
previously been diagnosed with melioidosis were insulin dependent; however,
information regarding insulin dependence for 140 of those patients was not available.
The group conjectured that since no records were available, it was “unlikely” that their
glycemia was being actively managed, and by extension, that those diabetic patients did
not have insulin deficiencies (52). They claimed that insulin was widely available in the
community, but did not provide any evidence that the claim or their suppositions were
valid. In a separate set of experiments, the group demonstrated that B. pseudomallei
growth was inhibited by m-cresol at concentrations found in common pharmaceutical
insulin preparations, but not by insulin alone. They concluded that the results of the
studies performed by Woods et al. may have been confounded by the effect of the insulin
preservatives used. Because some of the experiments performed by Woods et al. did not
involve pharmaceutical insulin preparations containing m-cresol, the effect of insulin on
B. pseudomallei growth remains unclear.
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It is possible that insulin affects melioidosis progression through mechanisms not
related to bacterial growth. As mentioned above, insulin is produced by the beta cells
within islets of Langerhans. Insulin reduces blood glucose by circulating in the blood
and binding receptor tyrosine kinase (RTK) receptors on muscle cells and adipocytes.
Insulin-receptor ligation activates signal transduction through a phosphoinositide
pathway that results in the activation of protein kinase B (PKB), which is able to induce
the fusion of GLUT4 glucose transformer-containing vesicles with the plasma membrane.
As the number of GLUT4 on the cell surface increases, glucose influx into the cell
increases, thereby lowering blood sugar. As insulin is removed, the GLUT4 molecules
are internalized by endocytosis, and subsequently, glucose transport from the blood into
the cell is reduced (38). In persons with type one diabetes mellitus, this process is
blunted or absent. It is possible that the transcription and proteomic processes
characteristic of defective insulin signaling renders diabetics more susceptible to B.
pseudomallei morbidity by interfering with or otherwise altering molecular processes
involved in immune activation.
The discovery that monocytes from male and female diabetic subjects produce
different cytokine profiles in response to infection with Burkholderia species is consistent
with studies indicating that males are more susceptible to diabetes (17) and studies
showing that some cytokines can be up- or down-regulated in response to the presence of
different sex hormones. Carruba et al. showed that PMA-differentiated macrophage-like
U937 cells treated with estrogen secreted increased levels of TNF-α and IL-10 (10), and
Schneider et al. demonstrated that androgens such as testosterone directly affected
cytokine production in various tissue macrophages (51). In addition, studies by de Groot
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et al. showed that gender has an effect on cytokine profiles in young pigs (20) and studies
by Stapleton et al. demonstrated that gender affects macrophage cytokine production after
trauma (53). Differences in cytokine secretion between genders are possibly due to
hormone-dependent effects; however, the mechanisms by which this phenomenon occurs
are still being elucidated. Synergistic effects of androgen and insulin signaling pathways
may affect macrophage cytokine production and other functions.
It is possible that the intracellular, intercellular, and/or the organ or tissue milieu
of diabetic males provides a particularly friendly environment for B. pseudomallei
organisms to set up a persistent infection. Evidence indicating that monocytes from
diabetic males have a blunted IL-8 response (Figure 12) coordinates nicely with data
suggesting that diabetics have decreased neutrophil infiltration at sites of infection (31),
since IL-8 is the primary chemokine responsible for neutrophil recruitment.
An interesting result of this study is that diabetic males secrete lower levels of IL1β in response to B. pseudoamallei infection. IL-1β is cleaved by interleukin-1
converting enzyme (ICE or Caspase 1) to a 17-kD mature form (22). IL-1β ligates its
cognate receptor on other immune cells and activates NF-κB signaling and subsequent
inflammatory responses. It has been shown that inhibiting caspase1 prevents apoptosis.
Whether Caspase 1 activity as ICE is related to its ability to induce apoptosis is not clear.
An interesting possibility is that B. pseudomallei may be able to survive in phagocytes
and other cells by inhibiting apoptosis.
The significant interactive effect of diabetic state and type of infective organism
on cytokine production by primary peripheral monocytes in response to infection with
Burkholderia species provides evidence that immune systems of persons with diabetes
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mellitus may respond differently to B. pseudomallei infections than to infections with
other agents. Many researchers believe that the devastating effects of septic shock are
due to an imbalance in activating and inhibitory cytokines rather than merely a drastic
increase in cytokine production (47).
We propose the following model for melioidosis progression in diabetic males:
After the host is exposed to B. pseudomallei, the organisms invade and replicate within
epithelial and phagocytic cells. During this period, the organisms may avoid critical host
immune responses because a) the host has blunted or imbalanced inflammatory responses
that prevent proper recruitment of neutrophils and lymphocytes b) the organisms are able
to prevent clearance by host defense mechanisms by escaping phagocytic vesicles using
type-three secretion system and by preventing lethal processes like the respiratory burst
in phagocytic cells. It is possible that after a period of time, a separate event or condition
triggers a renewed response to the organism that results in the septic shock that is
characteristic of acute melioidosis. The fact that nearly all persons in endemic areas are
seropositive for B. pseudomallei indicates that the organism’s virulence factors are
generally insufficient to cause disease, and that host susceptibility plays an important role
in B. pseudomallei pathogenesis. Defective host cytokine responses could account for
both the chronic and acute forms of melioidosis.
In conclusion, peripheral blood monocytes provide a meaningful model for
examining host innate immune responses to infection with B. pseudomallei. These
studies indicate that gender and diabetic state influence immunoregulatory macrophage
activities that are critical in determining whether the host’s immune responses to
infection will be successful.
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Table 1 Cytokines, Producer Cells, and Known Functions.*

Cytokine

Producer cell(s)

Function

IL-1α

Macrophages
Epithelial cells

Fever
T-cell activation
Macrophage activation

IL-1β

Macrophages
Epithelial cells

Fever
T-cell activation
Macrophage activation

IL-2

T cells

T-cell proliferation

IL-4

T cells
Mast cells

B-cell activation
IgE switch
Differentiation into Th2 cells

IL-5

T cells
Mast cells

Eosinophil growth
Differentiation

IL-6

T cells
Macrophages
Endothelial cells

T- and B-cell growth/differentiation
Acute phase protein production
Fever

IL-8

Monocytes/macrophages
Fibroblasts
Keratinocytes
Endothelial cells

Mobilizes, activates, and degranulates
neutrophils
Angiogenesis

IL-10

T cells
Macrophages
EBV-transformed cells

Potent suppressant of macrophage
functions

IL-13

T cells
Macrophages
Endothelial cells

B-cell growth/differentiation
Inhibits macrophage inflammatory
cytokine production and Th1 cells
Induces allergy/asthma

TNF-α

Macrophages
NK cells
T cells

Local inflammation
Endothelial activation

TNF-β

T cells
B cells

Killing
Endothelial activation

T cells
NK cells

Macrophage activation
Increased MHC molecules and antigen
processing components
Ig class switching
Supresses Th2

IFN-γ

*Adapted from Janeway et al. Immunobiology: the immune system in health and disease. 6th
edition.Garland Science Publishing, 2005. Pp. 80 and 747-49. Cytokines secreted by monocytes /
macrophages are shown in green.
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Figure 1. B. pseudomallei demonstrates variable colony morphologies in pure culture.
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Figure 2. Cytokine production by PMA-differentiated U937 macrophage-like cells
infected with B. pseudomallei, B. thailandensis, S. aureus, or E. coli.
One million cells were infected with an MOI of 6. Supernatants were collected 8 hours
post infection and assayed for cytokine levels using ELISA. Each point represents the
mean of at least three experiments. Standard errors are shown.
* indicates significant difference in cytokine production (p < 0.05).
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Figure 3 Kinetics of cytokine production by undifferentiated U937 monocyte-like cells
infected with B. pseudomallei, B. thailandensis, or E. coli.
One million cells were infected with an MOI of 6. Supernatant samples were collected 2,
4, 6, 9, 10, 12, 16, 20, and 24 hours post infection and assayed for cytokine levels using
ELISA.
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Figure 4. Kinetics of cytokine production by PMA-differentiated U937 macrophage-like
cells infected with B. pseudomallei, B. thailandensis, or E. coli.
One million cells were infected with an MOI of 6. Supernatant samples were collected 2,
4, 6, 9, 10, 12, 16, 20, and 24 hours post infection and assayed for cytokine levels using
ELISA.
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Figure 5. Kinetics of cytokine production by primary peripheral blood monocytes
infected with B. pseudomallei, B. thailandensis, or E. coli.
Primary human peripheral blood monocytes from healthy donors were infected with an
MOI of 6. Supernatant samples were collected 2, 4, 6, 9, 10, 12, 16, 20, and 24 hours post
infection and assayed for cytokine levels using ELISA.
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Figure 6. Kinetics of cytokine production by primary peripheral blood monocyte-derived
macrophages infected with B. pseudomallei, B. thailandensis, or E. coli.
Primary human peripheral blood monocyte-derived macrophages from healthy donors
were infected with an MOI of 6. Supernatant samples were collected 2, 4, 6, 9, 10, 12, 16,
20, and 24 hours post infection and assayed for cytokine levels using ELISA.

47

IL-1β, 10 hours post infection
4000

IL-1β concentration (pg/ml)

3500
3000
2500
2000
1500
1000
500
0

B. pseudomallei

B. thailandensis

E. coli

Uninfected
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experiments. Standard errors are shown.
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Figure 8. TNF-α production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli.
Primary human peripheral blood monocytes from diabetic or healthy donors were
infected with an MOI of 6. Supernatants were collected 10 hours post infection and
assayed for cytokine levels using ELISA. Each point represents the mean of at least five
experiments. Standard errors are shown.
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Figure 10. IL-1β production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli.
Primary human peripheral blood monocytes from diabetic or healthy donors were
infected with an MOI of 6. Supernatants were collected 10 hours post infection and
assayed for cytokine levels using ELISA. Each point represents the mean of at least five
experiments. Standard errors are shown.
* indicates significant difference in cytokine production (p < 0.05).
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Figure 11. IL-6 production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli.
Primary human peripheral blood monocytes from diabetic or healthy donors were
infected with an MOI of 6. Supernatants were collected 10 hours post infection and
assayed for cytokine levels using ELISA. Each point represents the mean of at least five
experiments. Standard errors are shown.
* indicates significant difference in cytokine production (p < 0.05).
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Figure 12. IL-8 production by primary monocytes from diabetic and control subjects in
response to infection with B. pseudomallei, B. thailandensis, and E. coli.
Primary human peripheral blood monocytes from diabetic or healthy donors were
infected with an MOI of 6. Supernatants were collected 10 hours post infection and
assayed for cytokine levels using ELISA. Each point represents the mean of at least five
experiments. Standard errors are shown.
* indicates significant difference in cytokine production (p < 0.05).
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Figure 13. IL-13 production by primary monocytes from diabetic and control subjects in
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